Alan Meds vs MadeMed
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
MadeMed
Best for Patients seeking a LegitScript-badged DTC platform with both injection and oral form factors for compounded semaglutide and tirzepatide, who are comfortable with pricing gated behind sign-up and limited public supply-chain disclosure.Side-by-Side Comparison
| Feature | Alan Meds | MadeMed |
|---|---|---|
| Overall Score | ✓7.7/10 | 5.6/10 |
| Starting Price | $99/mo | — |
| Editorial Rating | ✓3.9 ★ /5 | 2.8 ★ /5 |
| Features | 5 features | ✓8 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
MadeMed
Pros
- ✓Four distinct product offerings (injection + oral for both semaglutide and tirzepatide) gives needle-averse patients more options than most DTC competitors
- ✓LegitScript certification badge displayed on homepage
- ✓Customer phone support published (1-800-582-1428) — uncommon transparency vs chat-only competitors
- ✓Affiliate partnership available via Katalys network (RevOffers offer ID 1536)
Cons
- ✗Pricing NOT disclosed on the public homepage or product nav — fully gated behind product-page or checkout flow
- ✗LegitScript ID NUMBER not publicly displayed (only the certification badge)
- ✗Pharmacy partner NOT named
- ✗States-served list NOT disclosed publicly
- ✗Named medical director / clinician leadership NOT disclosed
- ✗503A vs 503B compounding designation NOT specified
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed
- ✗FDA compounded-medication disclaimer NOT visible on indexable HTML (site appears JavaScript-rendered)
- ✗Governing law / arbitration venue NOT disclosed
- ✗Oral compounded GLP-1 forms have weaker evidence base vs injectable (no STEP/SURMOUNT-equivalent oral compounded RCTs)
Our Verdict
Alan Meds edges out MadeMed with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. MadeMed remains a solid alternative, especially if you're looking for Patients seeking a LegitScript-badged DTC platform with both injection and oral form factors for compounded semaglutide and tirzepatide, who are comfortable with pricing gated behind sign-up and limited public supply-chain disclosure..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.